Correction  by unknown
I
D
H
G
p
2
O
I
R
I
2
O
L
s
I
I
h
m
Journal of the American College of Cardiology Vol. 53, No. 16, 2009
© 2009 by the American College of Cardiology Foundation ISSN 0735-1097/09/$36.00
Published by Elsevier Inc.CORRECTIONS
n the article by Epstein AE, DiMarco JP, Ellenbogen KA, et al., “ACC/AHA/HRS 2008 Guidelines for
evice-Based Therapy of Cardiac Rhythm Abnormalities: A Report of the American College of Cardiology/American
eart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002
uideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices),” which published ahead of
rint on May 15, 2008, and appeared in the May 27, 2008, online issue of the journal (J Am Coll Cardiol
008;51:e1–62), the following corrections were made:
n page e31, in Table 5:
• For the CABG-Patch trial (reference #328), the value of p (in the last column) changed from 0.63 to 0.64.
• For the AVID trial (reference #319), the value of p (in the last column) changed from NS to 0.02.
doi:10.1016/j.jacc.2009.03.009
n the article by Douglas PS, Hendel RC, Cummings JE, et al., “ACCF/ACR/AHA/ASE/ASNC/HRS/NASCI/
SNA/SAIP/SCAI/SCCT/SCMR 2008 Health Policy Statement on Structured Reporting in Cardiovascular
maging,” which published ahead of print on December 8, 2008, and appeared in the December 30, 2008/January 6,
009, issue of the journal (J Am Coll Cardiol 2009;53:76–90), the following correction is necessary:
n page 76, underneath the title, the following text should be added: Endorsed by the Society of Nuclear Medicine.
doi:10.1016/j.jacc.2009.03.014
opes RD, Alexander KP, Manoukian SV, et al. Advanced age, antithrombotic strategy, and bleeding in non–ST-
egment elevation acute coronary syndromes: results from the ACUITY (Acute Catheterization and Urgent
ntervention Triage Strategy) trial. J Am Coll Cardiol 2009;53:1021–30.
n this article, on page 1028, in the right column, the sentence on lines 8 –9 is missing the word “or.” The sentence should
ave read: “While bleeding may be a surrogate for greater comorbidity or may itself be an adverse clinical event, it is partly
odifiable.”
doi:10.1016/j.jacc.2009.03.012
